Do analysts recommend ACHV or SIGA?

Achieve Life Sciences currently has a consensus price target of $15.00, indicating a potential upside of 80.51%. Given Achieve Life Sciences' stronger consensus rating and higher probable upside, research analysts clearly believe Achieve Life Sciences is more favorable than Siga Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Achieve Life Sciences 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 2 Strong Buy rating(s) 3.00 Siga Technologies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to ACHV or SIGA?

In the previous week, Achieve Life Sciences had 8 more articles in the media than Siga Technologies. MarketBeat recorded 10 mentions for Achieve Life Sciences and 2 mentions for Siga Technologies. Achieve Life Sciences' average media sentiment score of 0.97 beat Siga Technologies' score of 0.37 indicating that Achieve Life Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Achieve Life Sciences 5 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Siga Technologies 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate GLAS or SIGA?

Glass House Brands currently has a consensus price target of $16.00, suggesting a potential upside of 86.70%. Given Glass House Brands' stronger consensus rating and higher probable upside, analysts clearly believe Glass House Brands is more favorable than Siga Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Glass House Brands 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Siga Technologies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, GLAS or SIGA?

Siga Technologies has higher revenue and earnings than Glass House Brands. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Glass House Brands N/A N/A N/A N/A N/A Siga Technologies $94.57M 2.45 $23.28M -$0.05 N/A

Does the media favor GLAS or SIGA?

In the previous week, Glass House Brands and Glass House Brands both had 2 articles in the media. Glass House Brands' average media sentiment score of 0.38 beat Siga Technologies' score of 0.37 indicating that Glass House Brands is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Glass House Brands 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Siga Technologies 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend SIGA or DRUG?

Bright Minds Biosciences has a consensus target price of $143.83, suggesting a potential upside of 111.46%. Given Bright Minds Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Bright Minds Biosciences is more favorable than Siga Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Siga Technologies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Bright Minds Biosciences 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.00

Does the media refer more to SIGA or DRUG?

In the previous week, Bright Minds Biosciences had 1 more articles in the media than Siga Technologies. MarketBeat recorded 3 mentions for Bright Minds Biosciences and 2 mentions for Siga Technologies. Bright Minds Biosciences' average media sentiment score of 0.95 beat Siga Technologies' score of 0.37 indicating that Bright Minds Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Siga Technologies 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Bright Minds Biosciences 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend OCS or SIGA?

Oculis presently has a consensus price target of $38.00, suggesting a potential upside of 212.24%. Given Oculis' stronger consensus rating and higher possible upside, analysts clearly believe Oculis is more favorable than Siga Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oculis 1 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.80 Siga Technologies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, OCS or SIGA?

Siga Technologies has higher revenue and earnings than Oculis. Siga Technologies is trading at a lower price-to-earnings ratio than Oculis, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Oculis $1.45M 486.63 -$119.44M -$1.74 N/A Siga Technologies $94.57M 2.45 $23.28M -$0.05 N/A

Is OCS or SIGA more profitable?

Siga Technologies has a net margin of -5.19% compared to Oculis' net margin of -6,777.18%. Siga Technologies' return on equity of -1.55% beat Oculis' return on equity. Company Net Margins Return on Equity Return on Assets Oculis -6,777.18% -42.61% -35.23% Siga Technologies -5.19% -1.55% -1.32%

Does the media favor OCS or SIGA?

In the previous week, Siga Technologies had 1 more articles in the media than Oculis. MarketBeat recorded 2 mentions for Siga Technologies and 1 mentions for Oculis. Oculis' average media sentiment score of 1.40 beat Siga Technologies' score of 0.37 indicating that Oculis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oculis 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Siga Technologies 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer SIGA or GYRE?

Gyre Therapeutics has a consensus price target of $16.00, indicating a potential upside of 148.45%. Given Gyre Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Gyre Therapeutics is more favorable than Siga Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Siga Technologies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Gyre Therapeutics 2 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.67

Does the media prefer SIGA or GYRE?

In the previous week, Siga Technologies had 1 more articles in the media than Gyre Therapeutics. MarketBeat recorded 2 mentions for Siga Technologies and 1 mentions for Gyre Therapeutics. Siga Technologies' average media sentiment score of 0.37 beat Gyre Therapeutics' score of 0.00 indicating that Siga Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Siga Technologies 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Gyre Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Siga Technologies (SIGA) Competitors

$3.23 +0.02 (+0.62%)

Closing price 09/3/2026 04:00 PM Eastern

Extended Trading

$3.17 -0.06 (-1.73%)

As of 04:00 AM Eastern

Compare

SIGA vs. ACHV, GLAS, DRUG, OCS, and GYRE

Should you buy Siga Technologies stock or one of its competitors? Siga Technologies's main competitors and comparable companies include Achieve Life Sciences (ACHV), Glass House Brands (GLAS), Bright Minds Biosciences (DRUG), Oculis (OCS), and Gyre Therapeutics (GYRE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Siga Technologies compare to Achieve Life Sciences?

Achieve Life Sciences (NASDAQ:ACHV) and Siga Technologies (NASDAQ:SIGA) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership.

Achieve Life Sciences has a net margin of 0.00% compared to Siga Technologies' net margin of -5.19%. Siga Technologies' return on equity of -1.55% beat Achieve Life Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Achieve Life Sciences	N/A	-511.12%	-82.35%
Siga Technologies	-5.19%	-1.55%	-1.32%

In the previous week, Achieve Life Sciences had 8 more articles in the media than Siga Technologies. MarketBeat recorded 10 mentions for Achieve Life Sciences and 2 mentions for Siga Technologies. Achieve Life Sciences' average media sentiment score of 0.97 beat Siga Technologies' score of 0.37 indicating that Achieve Life Sciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Achieve Life Sciences	5 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Siga Technologies	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

33.5% of Achieve Life Sciences shares are held by institutional investors. Comparatively, 55.4% of Siga Technologies shares are held by institutional investors. 1.8% of Achieve Life Sciences shares are held by company insiders. Comparatively, 2.7% of Siga Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Siga Technologies has higher revenue and earnings than Achieve Life Sciences. Siga Technologies is trading at a lower price-to-earnings ratio than Achieve Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Achieve Life Sciences	N/A	N/A	-$54.65M	-$1.55	N/A
Siga Technologies	$94.57M	2.45	$23.28M	-$0.05	N/A

Achieve Life Sciences has a beta of 2.25, suggesting that its stock price is 125% more volatile than the broader market. Comparatively, Siga Technologies has a beta of 0.97, suggesting that its stock price is 3% less volatile than the broader market.

Achieve Life Sciences currently has a consensus price target of $15.00, indicating a potential upside of 80.51%. Given Achieve Life Sciences' stronger consensus rating and higher probable upside, research analysts clearly believe Achieve Life Sciences is more favorable than Siga Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Achieve Life Sciences	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	3.00
Siga Technologies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Achieve Life Sciences beats Siga Technologies on 9 of the 16 factors compared between the two stocks.

How does Siga Technologies compare to Glass House Brands?

Glass House Brands (NYSE:GLAS) and Siga Technologies (NASDAQ:SIGA) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, media sentiment, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.

55.4% of Siga Technologies shares are held by institutional investors. 2.7% of Siga Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Glass House Brands currently has a consensus price target of $16.00, suggesting a potential upside of 86.70%. Given Glass House Brands' stronger consensus rating and higher probable upside, analysts clearly believe Glass House Brands is more favorable than Siga Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Glass House Brands	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Siga Technologies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Glass House Brands has a net margin of 0.00% compared to Siga Technologies' net margin of -5.19%. Glass House Brands' return on equity of 0.00% beat Siga Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Glass House Brands	N/A	N/A	N/A
Siga Technologies	-5.19%	-1.55%	-1.32%

In the previous week, Glass House Brands and Glass House Brands both had 2 articles in the media. Glass House Brands' average media sentiment score of 0.38 beat Siga Technologies' score of 0.37 indicating that Glass House Brands is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Glass House Brands	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Siga Technologies	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Siga Technologies has higher revenue and earnings than Glass House Brands.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Glass House Brands	N/A	N/A	N/A	N/A	N/A
Siga Technologies	$94.57M	2.45	$23.28M	-$0.05	N/A

Summary

Glass House Brands beats Siga Technologies on 7 of the 10 factors compared between the two stocks.

How does Siga Technologies compare to Bright Minds Biosciences?

Siga Technologies (NASDAQ:SIGA) and Bright Minds Biosciences (NASDAQ:DRUG) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations.

55.4% of Siga Technologies shares are owned by institutional investors. Comparatively, 40.5% of Bright Minds Biosciences shares are owned by institutional investors. 2.7% of Siga Technologies shares are owned by insiders. Comparatively, 42.7% of Bright Minds Biosciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Siga Technologies has a beta of 0.97, suggesting that its share price is 3% less volatile than the broader market. Comparatively, Bright Minds Biosciences has a beta of -5.36, suggesting that its share price is 636% less volatile than the broader market.

Siga Technologies has higher revenue and earnings than Bright Minds Biosciences. Siga Technologies is trading at a lower price-to-earnings ratio than Bright Minds Biosciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Siga Technologies	$94.57M	2.45	$23.28M	-$0.05	N/A
Bright Minds Biosciences	N/A	N/A	-$8.74M	-$2.08	N/A

Bright Minds Biosciences has a net margin of 0.00% compared to Siga Technologies' net margin of -5.19%. Siga Technologies' return on equity of -1.55% beat Bright Minds Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Siga Technologies	-5.19%	-1.55%	-1.32%
Bright Minds Biosciences	N/A	-12.46%	-12.30%

In the previous week, Bright Minds Biosciences had 1 more articles in the media than Siga Technologies. MarketBeat recorded 3 mentions for Bright Minds Biosciences and 2 mentions for Siga Technologies. Bright Minds Biosciences' average media sentiment score of 0.95 beat Siga Technologies' score of 0.37 indicating that Bright Minds Biosciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Siga Technologies	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Bright Minds Biosciences	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Bright Minds Biosciences has a consensus target price of $143.83, suggesting a potential upside of 111.46%. Given Bright Minds Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Bright Minds Biosciences is more favorable than Siga Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Siga Technologies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Bright Minds Biosciences	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	3.00

Summary

Bright Minds Biosciences beats Siga Technologies on 9 of the 16 factors compared between the two stocks.

How does Siga Technologies compare to Oculis?

Oculis (NASDAQ:OCS) and Siga Technologies (NASDAQ:SIGA) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership, media sentiment and dividends.

Siga Technologies has a net margin of -5.19% compared to Oculis' net margin of -6,777.18%. Siga Technologies' return on equity of -1.55% beat Oculis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oculis	-6,777.18%	-42.61%	-35.23%
Siga Technologies	-5.19%	-1.55%	-1.32%

Oculis presently has a consensus price target of $38.00, suggesting a potential upside of 212.24%. Given Oculis' stronger consensus rating and higher possible upside, analysts clearly believe Oculis is more favorable than Siga Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oculis	1 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.80
Siga Technologies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

22.3% of Oculis shares are held by institutional investors. Comparatively, 55.4% of Siga Technologies shares are held by institutional investors. 2.7% of Siga Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Siga Technologies has higher revenue and earnings than Oculis. Siga Technologies is trading at a lower price-to-earnings ratio than Oculis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oculis	$1.45M	486.63	-$119.44M	-$1.74	N/A
Siga Technologies	$94.57M	2.45	$23.28M	-$0.05	N/A

In the previous week, Siga Technologies had 1 more articles in the media than Oculis. MarketBeat recorded 2 mentions for Siga Technologies and 1 mentions for Oculis. Oculis' average media sentiment score of 1.40 beat Siga Technologies' score of 0.37 indicating that Oculis is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Oculis	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Siga Technologies	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Oculis has a beta of 0.52, indicating that its share price is 48% less volatile than the broader market. Comparatively, Siga Technologies has a beta of 0.97, indicating that its share price is 3% less volatile than the broader market.

Summary

Siga Technologies beats Oculis on 10 of the 16 factors compared between the two stocks.

How does Siga Technologies compare to Gyre Therapeutics?

Siga Technologies (NASDAQ:SIGA) and Gyre Therapeutics (NASDAQ:GYRE) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, dividends, profitability, media sentiment, institutional ownership and valuation.

In the previous week, Siga Technologies had 1 more articles in the media than Gyre Therapeutics. MarketBeat recorded 2 mentions for Siga Technologies and 1 mentions for Gyre Therapeutics. Siga Technologies' average media sentiment score of 0.37 beat Gyre Therapeutics' score of 0.00 indicating that Siga Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Siga Technologies	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Gyre Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

55.4% of Siga Technologies shares are held by institutional investors. Comparatively, 24.0% of Gyre Therapeutics shares are held by institutional investors. 2.7% of Siga Technologies shares are held by company insiders. Comparatively, 9.5% of Gyre Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Siga Technologies has a beta of 0.97, suggesting that its stock price is 3% less volatile than the broader market. Comparatively, Gyre Therapeutics has a beta of 1.92, suggesting that its stock price is 92% more volatile than the broader market.

Gyre Therapeutics has a consensus price target of $16.00, indicating a potential upside of 148.45%. Given Gyre Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Gyre Therapeutics is more favorable than Siga Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Siga Technologies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Gyre Therapeutics	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67

Siga Technologies has higher earnings, but lower revenue than Gyre Therapeutics. Siga Technologies is trading at a lower price-to-earnings ratio than Gyre Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Siga Technologies	$94.57M	2.45	$23.28M	-$0.05	N/A
Gyre Therapeutics	$116.59M	6.16	$5.03M	-$0.21	N/A

Siga Technologies has a net margin of -5.19% compared to Gyre Therapeutics' net margin of -15.47%. Siga Technologies' return on equity of -1.55% beat Gyre Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Siga Technologies	-5.19%	-1.55%	-1.32%
Gyre Therapeutics	-15.47%	-6.57%	-5.35%

Summary

Siga Technologies and Gyre Therapeutics tied by winning 8 of the 16 factors compared between the two stocks.

Get Siga Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SIGA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SIGA vs. The Competition

Export

Metric	Siga Technologies	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$230.64M	$12.25B	$7.26B	$12.73B
Dividend Yield	N/A	2.59%	2.53%	8.86%
P/E Ratio	-64.60	787.27	273.29	25.25
Price / Sales	2.45	754.88	623.67	97.64
Price / Cash	9.64	94.80	77.82	52.26
Price / Book	1.40	12.33	12.92	6.14
Net Income	$23.28M	$2.82B	$3.47B	$349.01M
7 Day Performance	5.56%	2.60%	0.60%	-0.27%
1 Month Performance	-0.31%	6.96%	5.72%	0.68%
1 Year Performance	-61.96%	9.45%	25.33%	14.84%

Siga Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SIGA Siga Technologies	0.1071 of 5 stars	$3.23 +0.6%	N/A	-62.5%	$230.64M	$94.57M	N/A	40	News Coverage
ACHV Achieve Life Sciences	3.1553 of 5 stars	$8.16 +2.7%	$15.00 +83.9%	+190.6%	$837.09M	N/A	N/A	20	News Coverage
GLAS Glass House Brands	2.8156 of 5 stars	$10.14 +2.6%	$16.00 +57.8%	N/A	$814.34M	N/A	N/A	N/A
DRUG Bright Minds Biosciences	2.5562 of 5 stars	$78.65 +2.1%	$143.83 +82.9%	+57.2%	$764.79M	N/A	N/A	N/A	News Coverage
OCS Oculis	2.8714 of 5 stars	$13.02 -1.3%	$38.00 +192.0%	-25.6%	$754.60M	N/A	N/A	2	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SIGA) was last updated on 9/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Siga Technologies (SIGA) Competitors

SIGA vs. ACHV, GLAS, DRUG, OCS, and GYRE

How does Siga Technologies compare to Achieve Life Sciences?

Summary

How does Siga Technologies compare to Glass House Brands?

Summary

How does Siga Technologies compare to Bright Minds Biosciences?

Summary

How does Siga Technologies compare to Oculis?

Summary

How does Siga Technologies compare to Gyre Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SIGA vs. The Competition

Siga Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Siga Technologies (SIGA) Competitors

SIGA vs. ACHV, GLAS, DRUG, OCS, and GYRE

How does Siga Technologies compare to Achieve Life Sciences?

Is ACHV or SIGA more profitable?

Does the media refer more to ACHV or SIGA?

Do institutionals and insiders have more ownership in ACHV or SIGA?

Which has stronger earnings and valuation, ACHV or SIGA?

Which has more volatility and risk, ACHV or SIGA?

Do analysts recommend ACHV or SIGA?

Summary

How does Siga Technologies compare to Glass House Brands?

Do insiders & institutionals hold more shares of GLAS or SIGA?

Do analysts rate GLAS or SIGA?

Is GLAS or SIGA more profitable?

Does the media favor GLAS or SIGA?

Which has better valuation and earnings, GLAS or SIGA?

Summary

How does Siga Technologies compare to Bright Minds Biosciences?

Do institutionals and insiders hold more shares of SIGA or DRUG?

Which has more volatility and risk, SIGA or DRUG?

Which has preferable valuation and earnings, SIGA or DRUG?

Is SIGA or DRUG more profitable?

Does the media refer more to SIGA or DRUG?

Do analysts recommend SIGA or DRUG?

Summary

How does Siga Technologies compare to Oculis?

Is OCS or SIGA more profitable?

Do analysts recommend OCS or SIGA?

Do institutionals & insiders hold more shares of OCS or SIGA?

Which has preferable valuation and earnings, OCS or SIGA?

Does the media favor OCS or SIGA?

Which has more risk & volatility, OCS or SIGA?

Summary

How does Siga Technologies compare to Gyre Therapeutics?

Does the media prefer SIGA or GYRE?

Do institutionals and insiders have more ownership in SIGA or GYRE?

Which has more risk and volatility, SIGA or GYRE?

Do analysts prefer SIGA or GYRE?

Which has higher valuation and earnings, SIGA or GYRE?

Is SIGA or GYRE more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SIGA vs. The Competition

Siga Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools